Chronic Lymphocytic Leukemia: What's New

Listen Now

Topics Covered

• Update on Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19 & Its Variants
• Current Treatment Options
• New & Emerging Treatment Approaches
• Clinical Trial Updates
• How Research Increases Treatment Options
• The Increasing Role of Telehealth/Telemedicine Appointments
• Communicating with Your Health Care Team about Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Adam S. Kittai, MD

Assistant Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center

Meghan Caitlin Thompson, MD

Fellow in Hematology & Medical Oncology, Memorial Sloan Kettering Cancer Center

Deborah M. Stephens, DO

Assistant Professor, Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, Physician Leader, Hematology Clinical Trials Research Group, Huntsman Cancer Institute, University of Utah

Patricia Koffman

Co-Founder and Communications Director, CLL Society, Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on March 17, 2022.